The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients.
Sara Lonardi(Istituto Oncologico Veneto), Silvia Marsoni(IFOM), Valter Torri(Istituti di Ricovero e Cura a Carattere Scientifico), Josep Tabernero(Deaconess Hospital), Andrea Sartore‐Bianchi(University of Milan), Elena Élez(Vall d'Hebron Hospital Universitari), Salvatore Siena(University of Milan), Stefania Mosconi(Ospedale Papa Giovanni XXIII), Paolo Luraghi(IFOM), Susana Muñoz(Vall d'Hebron Institute of Oncology), Noelia Tarazona(Universitat de València), Alberto Bardelli(IFOM), Filippo Pietrantonio(Fondazione IRCCS Istituto Nazionale dei Tumori), Maria Giulia Zampino(Azienda Ospedaliera Universitaria Pisana), Roberto Labianca(Ospedale Papa Giovanni XXIII), Luca Lazzari(Vita-Salute San Raffaele University), Clara Montagut(Hospital Del Mar), Alberto F. Sobrero(Ospedale Policlinico San Martino), Stefania Sciallero(Ospedale Policlinico San Martino)
Cited by 36
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k